NCT01645800已完成4 期
Effects of Lysozyme On Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 408
- 主要终点
- Acute exacerbation of COPD
研究概览
简要总结
The aim of this study is to assess the effectiveness in preventing exacerbation of 52 weeks lysozyme administration in patients with COPD.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 20 Years 至 84 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Lysozyme hydrochloride
Experimental
干预措施: Lysozyme hydrochloride (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Acute exacerbation of COPD
时间窗: 52 weeks
次要结局
- Yearly reduction in FEV1 and QOL assessed by CAT(52 weeks)
研究者
相似试验
未知
4 期
Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease (COPD)JPRN-jRCT1080222006Eisai Co., Ltd.400
已完成
4 期
Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum SymptomAsthmaChronic Obstructive Pulmonary DiseaseNCT01715493Eisai Co., Ltd.48
未知
4 期
Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum SymptomChronic Obstructive Pulmonary Disease (COPD) and AsthmaJPRN-jRCT1080222009Eisai Co., Ltd.48
已完成
不适用
The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung DiseaseChronic Lung DiseaseNCT02544984The University of Texas Health Science Center, Houston60
已完成
1 期
Open-label Trial to Evaluate the Effect Carbamazepine on Darigabat Pharmacokinetics in Healthy Adult ParticipantsHealthy ParticipantsNCT05824143Cerevel Therapeutics, LLC13